Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer

George N Sfakianakis

Research output: Chapter in Book/Report/Conference proceedingChapter


It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner.However, the utilization of telomeres in clinical practice for patient evaluation is stillin the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of Molecular Imaging(MI) in the evaluation of oncologic patients.

Original languageEnglish (US)
Title of host publicationImaging in Clinical Oncology
PublisherSpringer-Verlag Milan
Number of pages9
ISBN (Print)9788847053854, 9788847053847
StatePublished - Jan 1 2014


  • Biomarker
  • Hybrid imaging
  • Molecular imaging
  • Personalized therapy
  • Telomeres

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer'. Together they form a unique fingerprint.

Cite this